Eli Lilly and Company

Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania (2022) Simons G, Veldwijk J, Disantostefano RL, Englbrecht M, Radawski C, Bywall KS, Mendez LV, et al. Journal article Patient Characteristics and Treatment Patterns in European Pediatric Patients with Psoriasis: A Real-World, Cross-Sectional Study (2022) Sticherling M, Mcpherson T, Laguna RDL, Costanzo A, Reed C, Artime E, Robert C, et al. Journal article Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial. (2022) Paller AS, Seyger MMB, Magarinos GA, Pinter A, Cather JC, Rodriguez-Capriles C, Zhu D, et al. Journal article Burden of bowel urgency across specific treatment groups among Ulcerative Colitis patients - real world global study analyses (2022) Atreya R, Redondo I, Hill J, Streit P, Hartz S, Knight H, Barlow S, et al. Conference contribution Correction to: Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52 (Clinical Rheumatology, (2021), 40, 12, (4943-4954), 10.1007/s10067-021-05891-5) (2021) Behrens F, Leage SL, Sapin C, El Baou C, De La Torre I, Meszaros G, Schett G, et al. Journal article, Erratum Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52 (2021) Behrens F, Leage SL, Sapin C, El Baou C, De La Torre I, Meszaros G, Schett G, et al. Journal article PREFERENCES FOR TREATMENTS TO PREVENT RHEUMATOID ARTHRITIS: DISCRETE CHOICE SURVEY OF GENERAL POPULATIONS IN UNITED KINGDOM, GERMANY, AND ROMANIA (2021) Simons G, Veldwijk J, Di Santostefano R, Englbrecht M, Radawski C, Valor L, Raza K, Falahee M Journal article Treatment preferences for preventive interventions for rheumatoid arthritis: Protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project (2021) Falahee M, Simons G, Disantostefano RL, Valor Méndez L, Radawski C, Englbrecht M, Schölin Bywall K, et al. Journal article, Original article High Ki-67 as a biomarker for identifying patients with high risk early breast cancer treated in monarchE (2021) Harbeck N, Johnston S, Fasching P, Martin M, Toi M, Rastogi P, Song C, et al. Conference contribution Target Outcomes in Psoriatic Arthritis: Simultaneous Achievement of ACR50-Psoriasis Area and Severity Index 100 and Beyond: Insights from Open-Label, Assessor-Blinded Study at Week 24 (2020) Smolen J, Behrens F, Liu-Leage S, Sapin C, De La Torre I, Meszaros G, Schett G, et al. Conference contribution